Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2

Clinical Nephrology

Volumn 63, Issue 6, 2005, Pages 429-436

  Pham, P C T ^a   Pham, P M T ^b   Pham, P A T ^c   Pham, S V ^d   Pham, H V ^e   Miller, J M ^d   Yanagawa, N ^b   Pham, P T T ^f  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^b CENTRAL MAINE MEDICAL CENTER   (United States)

^c KAISER PERMANENTE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Laughlin AFB   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diabetes mellitus type 2; Kidney; Magnesium; Progression

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; MAGNESIUM ION;

ADULT; AGE DISTRIBUTION; ANALYTICAL PARAMETERS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HISTORY; HUMAN; HYPERTENSION; INFORMATION PROCESSING; INFORMATION RETRIEVAL; KIDNEY DYSFUNCTION; LINEAR REGRESSION ANALYSIS; LIPID ANALYSIS; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHARMACY; PREDICTION; PROTEINURIA; RETROSPECTIVE STUDY; SEX DIFFERENCE; TIME; UNITED STATES; URINALYSIS;

EID: 21044432738     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP63429     Document Type: Article

References (43)

1. Abbott LG, Rude RK 1993 Clinical manifestations of magnesium deficiency. Miner Electrolyte Metab 19: 314-322
2. Allen DA, Harwood S, Varagunam M, Raftery MJ, Yaqoob MH 2003 High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB J 17: 908-910
3. Altura BM, Altura BT, Gebrewold A, Ising H, Gunther T 1984 Magnesium deficiency and hypertension: correlation between magnesium-deficient diets and microcirculatory changes in situ. Science 223: 1315-1317
4. Amore A, Cappelli G, Cirina P, Conti G, Gambaruto C, Silvestro L, Coppo R 2003 Glucose degradation products increase apoptosis of human mesothelial cells. Nephrol Dial Transplant 18: 677-688
5. Arslanoglu I, Gunoz H, Bundak R, Saka N 1995 Hypomagnesaemia in childhood IDDM and risk of nephropathy. Diabetologia 38: 629-634
6. Balon TW, Gu JL, Tokuyama Y, Jasman AP, Nadler JL 1995 Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am J Physiol 269: E745-752
7. Ceriello A, Giugliano D, Dello Russo P, Passariello N 1982 Hypomagnesemia in relation to diabetic retinopathy. Diabetes Care 5: 558-559
8. Charpentier G, Genes N, Vaur L, Amar J, Clerson P, Cambou JP, Gueret P 2003 Espoir Diabetes Study Investigators. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey. Diabetes Metab 29: 152-158
9. Crook M, Couchman S, Tutt P, Amiel S, Swamenathan R 1994 Erythrocyte, plasma total, ultrafiltrable and platelet magnesium in type 2 (non-insulin-dependent) diabetes mellitus. Diabetes Res 27: 73-79
10. De Lourdes Lima M, Cruz T, Pousada JC, Rodrigues LE, Barbosa K, Cangucu V 1998 The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 21: 682-686
11. Duan HJ, Zhang YL, Shi YH, Liu F, Li YM 2002 Effects of benazepril on apoptosis in the kidney of diabetic rats. Yao Xue Xue Bao 37: 409-411
12. Garcia Vallejo O, Vicente Lozano J, Vegazo O, Jimenez JFJ, Llisterri Caro JL, Redon J 2003 Estuduio DIAPA. Control of blood pressure in diabetic patients in primary care setting. DIAPA Study (article in Spanish). Med Clin (Barc) 120: 529-534
13. Gong H, Amemiya T, Takaya K 2001 Retinal changes in magnesium-deficient rats. Exp Eye Res 72: 23-32
14. Gunther T, Vormann J, Hollriegl V 1995 Effects of magnesium and iron on lipid peroxidation in cultured hepatocytes. Mol Cell Biochem 144: 141-145
15. Hartwig A 2001 Role of magnesium in genomic stability. Mutat Res 475: 113-121
16. Hatwal A, Guyral AS, Bhatia RPS, Agrawal JK, Bajpai HS 1989 Association of hypomagnesemia with diabetic retinopathy. Acta Ophthalmol 67: 714-716
17. Ishii N, Ogawa Z, Suzuki K, Numakami K, Saruta T, Itoh H 1996 Glucose loading induces DNA fragmentation in rat proximal tubular cells. Metabolism 45: 1348-1353
18. Kao WHL, Folsom AR, Nieto J, Mo JP, Watson RL, Brancati FL 1999 Serum and dietary magnesium and the risk for type 2 diabetes mellitus. The Atherosclerosis Risk in Communities Study. Arch Intern Med 159: 2151-2159
19. Kharb S, Singh V 2000 Magnesium deficiency potentiates free radical production associated with myocardial infarction. J Assoc Physicians India 48: 484-485
20. Levey AS 1990 Measurement of renal function in chronic renal disease. Kidney Int 38: 167-184
21. Levin G, Mather H, Pilkington TRE 1981 Tissue magnesium status in diabetes mellitus. Diabetologia 21: 131-134
22. Martin H, Richert L, Berthelot A 2003 Magnesium deficiency induces apoptosis in primary cultures of rat hepatocytes. J Nutr 133: 2505-2511
23. Mather H, Nisbet JA, Burton GH, Poston GJ, Bland JM, Bailey PA, Pilkington TRE 1979 Hypomagnesemia in diabetes. Clin Chim Acta 95: 235-242
24. McNair P, Christiansen C, Madsbad S, Lauritzen E, Faber O, Binder C, Transbol I 1978 Hypomagnesemia, a risk factor in diabetic retinopathy. Diabetes 27: 1075-1077
25. McNair P, Christensen MS, Christiansen C, Madsbad S, Transbol I 1982 Renal hypomagnesemia in human diabetes mellitus: its relation to glucose homeostasis. Eur J Clin Invest 12: 81-85
26. Mikhail N, Ehsanipoor K 1999 Ionized serum magnesium in type 2 diabetes mellitus: its correlation with serum magnesium and hemoglobin A1C levels. South Med J 92: 1162-1166
27. Mitch WE, Walser M, Buffington GA, Lemann J 1976 A simple method for estimating progression of chronic renal failure. Lancet 2: 1326-1328
28. Nadler JL, Malayan S, Luong H, Shaw S, Natarajan RD, Rude RK 1992 Intracellular free magnesium deficiency plays a key role in increased platelet reactivity in type II diabetes mellitus. Diabetes Care 15: 835-841
29. Pickup JC, Chusney GD, Crook MA, Viberti GC 1994 Hypomagnesaemia in IDDM patients with microalbuminuria and clinical proteinuria. Diabetologia 37: 639-640
30. Rayssignier Y 1984 Role of magnesium and potassium in the pathogenesis of arteriosclerosis. Magnesium 3: 226-238
31. Resnick L, Altura BT, Gupta R, Laragh J, Alderman M, Altura BM 1993 Intracellular and extracellular magnesium depletion in type 2 (non-insulin-independent) diabetes mellitus. Diabetologia 36: 767-770
32. Rodriguez-Moran M, Guerrero-Romero F 2001 Low serum magnesium levels and foot ulcers in subjects with type 2 diabetes. Arch Med Res 32: 300-303
33. Sameshima H, Ikenoue T 2002 Effect of long-term, postasphyxial administration of magnesium sulfate on immunostaining of microtubule-associated protein-2 and activated caspase-3 in 7-day-old rat brain. J Soc Gynecol Invest 9: 203-209
34. Schaars CF, Denig P, Kasje WN, Stewart RE, Wolffenbuttel BH, Haaijer-Ruskamp FM 2004 Physician, organizational, and patient factors associated with suboptimal blood pressure management in type 2 diabetic patients in primary care. Diabetes Care 27: 123-128
35. Schlienger JL, Grunenberger F, Maier EA, Simon C, Chabrier G, Leroy MJ 1988 Disorders of plasma trace elements in diabetes. Relation to blood glucose equilibrium. Presse Med 17: 1076-1079
36. Shivakumar K 2002 Pro-fibrogenic effects of magnesium deficiency in the cardiovascular system. Magnes Res 15: 307-315
37. Shivakumar K, Kumar BP 1997 Magnesium deficiency enhances oxidative stress and collagen synthesis in vivo in the aorta of rats. Int J Biochem Cell Biol 29: 1273-1278
38. Sjogren A, Flore CH, Nilsson A 1986 Magnesium deficiency in IDDM related to level of glycosylated hemoglobin. Diabetes 35: 459-463
39. Sjogren A, Floren CH, Nilsson A 1988 Magnesium, potassium and zinc deficiency in subjects with type II diabetes mellitus. Acta Med Scand 224: 461-466
40. Vanroelen WF, Gaal L, Van Rooy PE, De Leeuw IH 1985 Serum and erythrocyte magnesium level in type I and type II diabetics. Acta Diabetol 22: 185-190
41. Wiles ME, Wagner TL, Reglicki WB 1997 Effect of acute magnesium deficiency (MgD) on aortic endothelial cell (EC) oxidant production. Life Sci 60: 221-236
42. Yamagishi S, Inagaki Y, Okamoto T, Amano S, Koga K, Takeuchi M, Makita Z 2002 Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. J Biol Chem 277: 20309-20315
43. Zhou Q, Olinescu RM, Kummerow FA 1999 Influence of low magnesium concentrations in the medium on the antioxidant system in cultured human arterial endothelial cells. Magnes Res 12: 19-29